Ischemic preconditioning--do we need more (pharmacological) experiments?
de Jong
J W
JW
Cardiochemical Laboratory, Erasmus University Rotterdam, The Netherlands.
de Jonge
R
R
D000241:Adenosine / Q000031:analogs & derivatives* / Q000378:metabolism / Q000627:therapeutic use; D000818:Animals; D001783:Blood Flow Velocity / Q000187:drug effects; D001920:Bradykinin / Q000378:metabolism; D003331:Coronary Vessels / Q000187:drug effects / Q000503:physiopathology; D006801:Humans; D019157:Ischemic Preconditioning, Myocardial / Q000379:methods; D017202:Myocardial Ischemia / Q000378:metabolism / Q000503:physiopathology / Q000517:prevention & control*; D009638:Norepinephrine / Q000378:metabolism; D058906:Purinergic P1 Receptor Agonists
D058906:Purinergic P1 Receptor Agonists; C027513:N(6)-cyclohexyladenosine; C058394:2-chloro-N(6)cyclopentyladenosine; D000241:Adenosine; D001920:Bradykinin; D009638:Norepinephrine